Tracking your tardive dyskinesia symptoms provides insight into what’s going on. Tardive dyskinesia (TD) is a movement disorder that causes certain uncontrollable movements in different parts of ...

Fear of unwanted attention causes some people to withdraw from friends and family, especially if symptoms are severe. One way to help manage the stigma of tardive dyskinesia is to learn everything ...

By examining over 3,000 neurons in the motor cortex of rats exhibiting symptoms of dyskinesia, the study uncovered that the motor cortex becomes disconnected from movement control during ...

High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD ... and rapidly improved TD symptoms compared to placebo, reducing ...

July 8, 2024 — By prohibiting the Activin A protein from functioning, researchers were able to halt the development of dyskinesia symptoms and effectively erase the brain's 'bad memory' response to ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...

"As the motor symptoms of Parkinson's disease worsen over time ... portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) ...

The dynamics of the multiple system atrophy treatment market is anticipated to change during the forecast period as companies across the 7MM are diligently working towards the development of novel ...